Great to see ARYC finally file the s-1 . Still lots of vagueness from the company like always. So ARYC shareholders get 1 AD per 3 shares of ARYC held. Great news if there is a demand for ARYC and AD stock which the company still has yet to be able to create. No mention of FDA approval or ex dividend date to receive the shares? VRML's market cap is now 19 million and has had a complete failure with Quest to generate any revenue with it's ovarian test for several years now makes it look like a long shot and an uphill battle for ARYC until they come out with some blockbuster news of how they plan to make money for the company and shareholders. Stay tuned and keep waiting is the ARYC theme it seems...